HCT Stock Overview
Holista CollTech Limited operates as a research-driven biotech company in Australia, Malaysia, and the United States.
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 0/6 |
| Dividends | 0/6 |
Holista Colltech Limited Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | AU$0.01 |
| 52 Week High | AU$0.017 |
| 52 Week Low | AU$0.009 |
| Beta | -0.58 |
| 1 Month Change | 0% |
| 3 Month Change | -9.09% |
| 1 Year Change | -37.50% |
| 3 Year Change | -81.13% |
| 5 Year Change | -85.29% |
| Change since IPO | -92.31% |
Recent News & Updates
Recent updates
Shareholder Returns
| HCT | AU Personal Products | AU Market | |
|---|---|---|---|
| 7D | 0% | -1.2% | -2.8% |
| 1Y | -37.5% | -5.5% | 4.0% |
Return vs Industry: HCT underperformed the Australian Personal Products industry which returned -5.5% over the past year.
Return vs Market: HCT underperformed the Australian Market which returned 4% over the past year.
Price Volatility
| HCT volatility | |
|---|---|
| HCT Average Weekly Movement | n/a |
| Personal Products Industry Average Movement | 5.4% |
| Market Average Movement | 9.0% |
| 10% most volatile stocks in AU Market | 17.4% |
| 10% least volatile stocks in AU Market | 3.5% |
Stable Share Price: HCT has not had significant price volatility in the past 3 months.
Volatility Over Time: Insufficient data to determine HCT's volatility change over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| n/a | n/a | n/a | www.holistaco.com |
Holista CollTech Limited operates as a research-driven biotech company in Australia, Malaysia, and the United States. The company operates through Supplements, Ovine Collagen, Infection control Solutions, Food Ingredients, and Corporate segments. It manufactures and wholesales dietary supplements; cosmetic grade collagen; infection control solutions; and healthy food ingredients, including low- Glycemic index (GI) bread, noodles/ pasta, and flatbreads as well as a low-calorie/Low-GI sugar substitute.
Holista Colltech Limited Fundamentals Summary
| HCT fundamental statistics | |
|---|---|
| Market cap | AU$2.79m |
| Earnings (TTM) | -AU$4.81m |
| Revenue (TTM) | AU$5.95m |
0.5x
P/S Ratio-0.6x
P/E RatioIs HCT overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| HCT income statement (TTM) | |
|---|---|
| Revenue | AU$5.95m |
| Cost of Revenue | AU$3.32m |
| Gross Profit | AU$2.62m |
| Other Expenses | AU$7.43m |
| Earnings | -AU$4.81m |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.017 |
| Gross Margin | 44.10% |
| Net Profit Margin | -80.81% |
| Debt/Equity Ratio | -39.5% |
How did HCT perform over the long term?
See historical performance and comparison